Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,307.20 -80.41 -0.52%
S&P 500 1,655.35 -13.81 -0.83%
Nasdaq 3,463.30 -38.82 -1.11%
Ticker Volume Price Price Delta
STOXX 50 2,762.66 -72.35 -2.55%
FTSE 100 6,709.35 -130.92 -1.91%
DAX 8,303.34 -227.55 -2.67%
Ticker Volume Price Price Delta
Nikkei 14,484.00 -1,143.28 -7.32%
Hang Seng 22,669.70 -591.40 -2.54%
S&P/ASX 200 5,062.45 -102.92 -1.99%
  • Exchange: NASDAQ GM
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Therapeutics

Sarepta Therapeutics Inc

+ Add to Watchlist

SRPT:US

36.3200 USD 0.3300 0.90%

As of 20:10:00 ET on 05/22/2013.

Company Profile for Sarepta Therapeutics Inc (SRPT)

Sarepta Therapeutics, Inc. is a biopharmaceutical company focused on the discovery and development of unique RNA-based therapeutics for the treatment of both rare and infectious diseases. The Company offers its products to the medical industry in countries around the world.

Contact Information

Sarepta Therapeutics Inc

3450 Monte Villa Parkway
Suite 101
Bothell, WA 98021
United States
Phone: 1-425-354-5140

Key Executives for Sarepta Therapeutics Inc (SRPT)

Christopher N GarabedianPresident/CEOSandesh Mahatme "Sandy"Senior VP/CFO
Edward M KayeSenior VP/Chief Medical OfficerDavid Tyronne Howton "Ty"Senior VP/Secretary/Gen Counsel
Jayant AphaleSenior VP:Technical OperationsMichael A JacobsenVP:Finance/Principal Acctg Ofcr

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil